Search

everythinglearnresearchcommunity

for

Search:↓

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Early treatment helps stop hair loss in women of color.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Treat pattern hair loss with finasteride and topical minoxidil.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Antiandrogen therapy helps treat genetic hair loss.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.